showed that several targets of miR-1 are involved in progressive myocardial hypertrophy and cardiac remodeling, including Ras GTPase-activating protein (RasGAP) and cyclin-dependent kinase 9 (Cdk9), activators of cardiac hypertrophy,22,23 Ras homolog enriched in brain (Rheb), an upstream activator of protein synthesis, and the cell growth-related mammalian target of rapamycin (mTOR)/S6 kinase pathway.24 The gene discussed is RASA2; the disease is cardiac hypertrophy.